アッヴィ株式会社
MX ˙ BMV ˙ US00287Y1091
SecurityMX:ABBV / AbbVie Inc.
InstitutionRadnor Capital Management, LLC
Latest Disclosed Ownership23,869 shares
Latest Disclosed Value $ 5,191,269
Radnor Capital Management, LLC reports 0.73% decrease in ownership of ABBV / AbbVie Inc.

On April 15, 2026 - Radnor Capital Management, LLC filed a 13F-HR form disclosing ownership of 23,869 shares of AbbVie Inc. (MX:ABBV) valued at $5,191,269 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 24,044 shares of AbbVie Inc.. This represents a change in shares of -0.73% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F ABBVIE COM 00287Y109 23,869 -175 -0.73 5,191 -5.50 0.7682
2026-02-06 2025-12-31 13F ABBVIE COM 00287Y109 24,044 -1,023 -4.08 5,494 -5.36 0.8154
2025-10-21 2025-09-30 13F ABBVIE COM 00287Y109 25,067 -123 -0.49 5,804 145,000.00 0.8829
2025-07-09 2025-06-30 13F ABBVIE COM 00287Y109 25,190 629 2.56 5 -20.00 0.7460
2025-04-11 2025-03-31 13F ABBVIE COM 00287Y109 24,561 -86 -0.35 5 25.00 0.8621
2025-01-14 2024-12-31 13F ABBVIE COM 00287Y109 24,647 -3,268 -11.71 4 -20.00 0.7319
2024-10-30 2024-09-30 13F ABBVIE COM 00287Y109 27,915 2,561 10.10 6 25.00 0.8187
2024-07-12 2024-06-30 13F ABBVIE COM 00287Y109 25,354 260 1.04 4 0.00 1.3261
2024-04-11 2024-03-31 13F ABBVIE COM 00287Y109 25,094 -2,591 -9.36 5 0.00 0.7792
2024-01-11 2023-12-31 13F ABBVIE COM 00287Y109 27,685 273 1.00 4 0.00 0.8001
2023-10-12 2023-09-30 13F ABBVIE COM 00287Y109 27,412 2,017 7.94 4 33.33 0.8129
2023-07-07 2023-06-30 13F ABBVIE COM 00287Y109 25,395 8,829 53.30 3 50.00 1.4619
2023-04-06 2023-03-31 13F ABBVIE COM 00287Y109 16,566 1,200 7.81 3 0.00 0.6946
2023-01-09 2022-12-31 13F ABBVIE COM 00287Y109 15,366 -707 -4.40 3 -99.91 0.6194
2022-10-12 2022-09-30 13F ABBVIE COM 00287Y109 16,073 -40 -0.25 2,157 -12.60 0.6255
2022-07-11 2022-06-30 13F ABBVIE COM 00287Y109 16,113 469 3.00 2,468 -2.68 0.6750
2022-04-25 2022-03-31 13F ABBVIE COM 00287Y109 15,644 433 2.85 2,536 23.11 0.6363
2022-01-20 2021-12-31 13F ABBVIE COM 00287Y109 15,211 3,307 27.78 2,060 60.44 0.5087
2021-10-26 2021-09-30 13F ABBVIE COM 00287Y109 11,904 450 3.93 1,284 -0.47 0.7625
2021-07-21 2021-06-30 13F ABBVIE COM 00287Y109 11,454 150 1.33 1,290 5.48 0.4354
2021-04-26 2021-03-31 13F ABBVIE COM 00287Y109 11,304 300 2.73 1,223 3.73 0.3934
2021-01-13 2020-12-31 13F ABBVIE COM 00287Y109 11,004 535 5.11 1,179 28.57 0.3326
2020-11-02 2020-09-30 13F ABBVIE COM 00287Y109 10,469 850 8.84 917 -3.88 0.3072
2020-07-28 2020-06-30 13F ABBVIE COM 00287Y109 9,619 1,444 17.66 954 53.38 0.3446
2020-04-07 2020-03-31 13F ABBVIE COM 00287Y109 8,175 0 0.00 622 -14.09 0.2552
2020-01-10 2019-12-31 13F ABBVIE COM 00287Y109 8,175 0 0.00 724 16.96 0.2244
2019-10-07 2019-09-30 13F ABBVIE COM 00287Y109 8,175 0 0.00 619 4.21 0.2029
2019-07-18 2019-06-30 13F ABBVIE COM 00287Y109 8,175 3,850 89.02 594 70.20 0.1955
2019-04-25 2019-03-31 13F ABBVIE COM 00287Y109 4,325 -775 -15.20 349 -25.74 0.1142
2019-01-16 2018-12-31 13F ABBVIE COM 00287Y109 5,100 0 0.00 470 -2.49 0.1696
2018-10-04 2018-09-30 13F ABBVIE COM 00287Y109 5,100 500 10.87 482 13.15 0.1533
2018-07-10 2018-06-30 13F Abbvie COM 00287Y109 4,600 0 0.00 426 -2.07 0.1579
2018-04-20 2018-03-31 13F ABBVIE COM 00287Y109 4,600 -391 -7.83 435 -9.94 0.1479
2018-02-02 2017-12-31 13F Abbvie COM 00287Y109 4,991 -100 -1.96 483 30.89 0.1545
2017-10-10 2017-09-30 13F Abbvie COM 00287Y109 5,091 0 0.00 369 0.00 0.1249
2017-08-09 2017-06-30 13F Abbvie COM 00287Y109 5,091 -870 -14.59 369 -4.90 0.1249
2017-04-20 2017-03-31 13F ABBVIE COM 00287Y109 5,961 0 0.00 388 4.02 0.1311
2017-02-03 2016-12-31 13F ABBVIE COM 00287Y109 5,961 5,961 373 0.1277
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.